Albert David Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.9 pts less than Nifty Microcap 250 and 7.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Albert David Limited's board approved audited financial results for Q4 and FY ended March 31, 2025, with an unmodified audit opinion from L.B. Jha & Co. Revenue from operations declined about 4.6% YoY to Rs. 34,576.80 lakh (from Rs. 36,246.17 lakh). Profit after tax fell sharply by roughly 77% to Rs. 1,720.08 lakh (from Rs. 7,542.01 lakh), and the company swung to a loss in Q4 FY25 of Rs. 1,032.79 lakh versus a profit in Q4 FY24. The board recommended a final dividend of Rs. 5 per share (50% on Rs. 10 face value) with record date July 25, 2025 and AGM on August 2, 2025. Operating cash flow turned sharply negative at Rs. (2,843.58) lakh versus Rs. 4,550.22 lakh last year. PwC was reappointed as internal auditor, MKB & Associates appointed as secretarial auditor for 5 years, and S. Gupta & Co. reappointed as cost auditor.
Despite a strong dividend declaration, shareholders should note the steep drop in annual profits, a quarterly loss, and a significant swing to negative operating cash flow, which signal pressure on core earnings quality. The unchanged audit opinion and stable dividend may provide some support, but the weak results are likely to weigh on near-term sentiment.